NeOnc Technologies Holdings is offering common stock, pre-funded warrants and warrants for approximately $15 million, with a combined price of $4.20 per share and accompanying warrant. The proceeds are intended for working capital, general corporate purposes and Redemption of Series A Convertible Preferred Stock, while the warrants create immediate exercise rights.

Key Highlights

  • The securities package includes 2,610,715 common shares and pre-funded warrants covering up to 960,715 shares.
  • Accompanying warrants cover up to an aggregate of 3,571,430 common shares.
  • The warrants have a $4.20 exercise price and expire five years after issuance.

NEONC TECHNOLOGIES HOLDINGS, INC. (NASDAQ: NTHI) is pursuing a registered direct offering expected to generate approximately $15 million in gross proceeds.

Securities Package Sets Share and Warrant Terms

The securities purchase agreements cover the sale of 2,610,715 common shares, pre-funded warrants for up to 960,715 shares and accompanying warrants exercisable for up to an aggregate of 3,571,430 common shares. The combined price is $4.20 per share and accompanying warrant, while each pre-funded warrant costs that amount less its $0.0001 exercise price. The offering had an expected closing date of September 10, 2026, subject to customary closing conditions. NeOnc Technologies also agreed to post-closing restrictions on certain new stock issuances and registration statements, while its Chief Executive Officer and Chief Medical Officer entered into lock-up agreements.

Immediate Exercise Rights Extend to 2031

The warrants carry a $4.20 exercise price per common share and become exercisable immediately after issuance, subject to beneficial ownership limits. Their stated termination date is September 10, 2031. The pre-funded warrants also become exercisable upon issuance, subject to those limits, and remain exercisable until fully exercised. The common shares, pre-funded warrants and related warrant shares were offered under a prospectus supplement dated September 8, 2026, alongside a prospectus dated April 9, 2026.